Published in Sleep on May 01, 2005
Sleep duration in the United States: a cross-sectional population-based study. Am J Epidemiol (2009) 3.84
Sleep hygiene behaviors among midlife women with insomnia or sleep-disordered breathing: the SWAN sleep study. J Womens Health (Larchmt) (2014) 1.58
Prevalence and polysomnographic correlates of insomnia comorbid with medical disorders. Sleep (2011) 1.35
The role of sleep hygiene in promoting public health: A review of empirical evidence. Sleep Med Rev (2014) 1.12
Prevalence, severity, and correlates of sleep-wake disturbances in long-term breast cancer survivors. J Pain Symptom Manage (2010) 1.10
Stress-related sleep disturbance and polysomnographic response to caffeine. Sleep Med (2006) 1.06
Effects of an irregular bedtime schedule on sleep quality, daytime sleepiness, and fatigue among university students in Taiwan. BMC Public Health (2009) 1.01
Alcohol and sleep problems in primary care patients: a report from the AAFP National Research Network. Ann Fam Med (2010) 0.97
Is passive smoking associated with sleep disturbance among pregnant women? Sleep (2007) 0.89
Sleep hygiene awareness: its relation to sleep quality and diurnal preference. J Mol Psychiatry (2015) 0.87
The nature of stable insomnia phenotypes. Sleep (2015) 0.85
Cognitive behavioral treatment of insomnia. Chest (2013) 0.85
Joint effect of alcohol and usual sleep duration on the risk of dysglycemia. Sleep (2007) 0.79
Stress-related sleep vulnerability and maladaptive sleep beliefs predict insomnia at long-term follow-up. J Clin Sleep Med (2014) 0.78
Towards quantitative cutoffs for insomnia: how current diagnostic criteria mischaracterize remission. Sleep Med (2016) 0.78
Social networks and future direction for obesity research: A scoping review. Nurs Outlook (2014) 0.78
Sleep Hygiene Pattern and Behaviors and Related Factors among General Population in West Of Iran. Glob J Health Sci (2015) 0.77
Selected neurophysiological, psychological, and behavioral influences on subjective sleep quality in nurses: a structure equation model. PLoS One (2013) 0.76
Psychometric Properties of the Persian Version of Sleep Hygiene Index in the General Population. Iran J Psychiatry Behav Sci (2016) 0.75
The impact of sleep healthy behavior education on the quality of life in the pregnant women with sleep disorder: A randomized control trial in the year 2012. Iran J Nurs Midwifery Res (2014) 0.75
Sleep Deprivation and Late Bedtime Impair Sperm Health Through Increasing Antisperm Antibody Production: A Prospective Study of 981 Healthy Men. Med Sci Monit (2017) 0.75
Effect of Sleep Hygiene Education on Sleep Quality in Hemodialysis Patients. J Clin Diagn Res (2016) 0.75
The effect of sleep health behavioral education on the depression of pregnant women with sleep disorders: a randomized control trial. Iran Red Crescent Med J (2015) 0.75
History of the development of sleep medicine in the United States. J Clin Sleep Med (2005) 4.22
Shift work sleep disorder: prevalence and consequences beyond that of symptomatic day workers. Sleep (2004) 3.78
Sleep loss and REM sleep loss are hyperalgesic. Sleep (2006) 3.03
Place of chronic insomnia in the course of depressive and anxiety disorders. J Psychiatr Res (2002) 2.99
Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry (2006) 2.86
The association of insomnia with anxiety disorders and depression: exploration of the direction of risk. J Psychiatr Res (2006) 2.60
Modafinil for excessive sleepiness associated with shift-work sleep disorder. N Engl J Med (2005) 2.51
Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res (2002) 2.48
Early CPAP use identifies subsequent adherence to CPAP therapy. Sleep (2007) 2.19
Sleep in lifetime posttraumatic stress disorder: a community-based polysomnographic study. Arch Gen Psychiatry (2004) 2.13
Epidemiology of DSM-IV insomnia in adolescence: lifetime prevalence, chronicity, and an emergent gender difference. Pediatrics (2006) 2.06
The association between obesity and short sleep duration: a population-based study. J Clin Sleep Med (2005) 1.87
The pediatric daytime sleepiness scale (PDSS): sleep habits and school outcomes in middle-school children. Sleep (2003) 1.86
Vulnerability to stress-related sleep disturbance and hyperarousal. Sleep (2004) 1.84
Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant. Neurology (2012) 1.83
Insomnia and the performance of US workers: results from the America insomnia survey. Sleep (2011) 1.77
Sleep, sleepiness, sleep disorders and alcohol use and abuse. Sleep Med Rev (2001) 1.75
Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol (2009) 1.73
Using difficulty resuming sleep to define nocturnal awakenings. Sleep Med (2010) 1.73
Insomnia: epidemiology, characteristics, and consequences. Clin Cornerstone (2003) 1.72
Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations. Sleep (2007) 1.72
Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials. Lancet (2008) 1.72
The scoring of arousal in sleep: reliability, validity, and alternatives. J Clin Sleep Med (2007) 1.71
Insomnia causes, consequences, and therapeutics: an overview. Depress Anxiety (2003) 1.54
Burden associated with chronic sleep maintenance insomnia characterized by nighttime awakenings among women with menopausal symptoms. Menopause (2010) 1.52
Efficacy and safety of zolpidem extended release in elderly primary insomnia patients. Am J Geriatr Psychiatry (2008) 1.51
Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial. Am J Gastroenterol (2005) 1.48
Patient-reported outcomes in insomnia: development of a conceptual framework and endpoint model. Behav Sleep Med (2013) 1.43
Caffeine: sleep and daytime sleepiness. Sleep Med Rev (2007) 1.41
Insomnia: pathophysiology and implications for treatment. Sleep Med Rev (2006) 1.41
Armodafinil for treatment of excessive sleepiness associated with shift work disorder: a randomized controlled study. Mayo Clin Proc (2009) 1.38
Sleep during titration predicts continuous positive airway pressure compliance. Sleep (2003) 1.37
Sleep and pain: interaction of two vital functions. Semin Neurol (2005) 1.37
Prevalence and polysomnographic correlates of insomnia comorbid with medical disorders. Sleep (2011) 1.35
Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia. Curr Med Res Opin (2004) 1.29
The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy. Curr Med Res Opin (2006) 1.28
The 10-year risk of verified motor vehicle crashes in relation to physiologic sleepiness. Sleep (2010) 1.25
Standard operation procedures for conducting the on-the-road driving test, and measurement of the standard deviation of lateral position (SDLP). Int J Gen Med (2011) 1.24
Nighttime insomnia symptoms and perceived health in the America Insomnia Survey (AIS). Sleep (2011) 1.19
Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia. J Clin Sleep Med (2007) 1.17
Ethanol and sleep loss: a "dose" comparison of impairing effects. Sleep (2003) 1.17
The prevalence of multiple sleep-onset REM periods in a population-based sample. Sleep (2006) 1.17
Pharmacologic management of insomnia in children and adolescents: consensus statement. Pediatrics (2006) 1.16
Gender differences in pharmacokinetics and pharmacodynamics of zolpidem following sublingual administration. J Clin Pharmacol (2013) 1.16
Shift work sleep disorder: burden of illness and approaches to management. Drugs (2006) 1.15
Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. Arch Gen Psychiatry (2008) 1.15
Zolpidem for insomnia. Expert Opin Pharmacother (2012) 1.14
Periodic limb movements during sleep: population prevalence, clinical correlates, and racial differences. Sleep (2008) 1.13
MSLT in primary insomnia: stability and relation to nocturnal sleep. Sleep (2011) 1.13
Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial. J Clin Psychiatry (2010) 1.13
Sleep disturbance in psychiatric disorders: effects on function and quality of life in mood disorders, alcoholism, and schizophrenia. Ann Clin Psychiatry (2008) 1.12
Tolerance to daytime sedative effects of H1 antihistamines. J Clin Psychopharmacol (2002) 1.09
Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial. Obstet Gynecol (2006) 1.09
Reliability and validity of the brief insomnia questionnaire in the America insomnia survey. Sleep (2010) 1.08
The health effects of at-home written emotional disclosure in fibromyalgia: a randomized trial. Ann Behav Med (2006) 1.08
The associations of insomnia with costly workplace accidents and errors: results from the America Insomnia Survey. Arch Gen Psychiatry (2012) 1.07
Consequences of shiftworking on sleep duration, sleepiness, and sleep attacks. Chronobiol Int (2010) 1.07
Stress-related sleep disturbance and polysomnographic response to caffeine. Sleep Med (2006) 1.06
Assessment of multiple health risks in a single obstructive sleep apnea population. J Clin Sleep Med (2012) 1.05
Insomnia pharmacotherapy. Neurotherapeutics (2012) 1.05
Tiagabine is associated with sustained attention during sleep restriction: evidence for the value of slow-wave sleep enhancement? Sleep (2006) 1.04
Sleep reactivity and insomnia: genetic and environmental influences. Sleep (2011) 1.03
Nocturnal rapid eye movement sleep latency for identifying patients with narcolepsy/hypocretin deficiency. JAMA Neurol (2013) 1.02
Pain sensitivity in sleepy pain-free normals. Sleep (2009) 1.02
Safety of ramelteon in individuals with mild to moderate obstructive sleep apnea. Sleep Breath (2007) 1.02
Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depression. J Clin Sleep Med (2007) 1.01
Neurophysiology of sleep and wakefulness: basic science and clinical implications. Curr Neuropharmacol (2008) 1.01
Psychomotor functioning and alertness with guanfacine extended release in subjects with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol (2011) 1.01
The venom composition of the parasitic wasp Chelonus inanitus resolved by combined expressed sequence tags analysis and proteomic approach. BMC Genomics (2010) 1.00
Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia. Sleep (2011) 0.99
Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover study. J Clin Psychiatry (2008) 0.99
Pain sensitivity and recovery from mild chronic sleep loss. Sleep (2012) 0.99
Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia. Sleep (2010) 0.97
Cortical locations of maximal spindle activity: magnetoencephalography (MEG) study. J Sleep Res (2009) 0.97
'Hypnotic' prescription patterns in a large managed-care population. Sleep Med (2004) 0.97
Caffeine reversal of ethanol effects on the multiple sleep latency test, memory, and psychomotor performance. Neuropsychopharmacology (2002) 0.96
Circadian phase, sleepiness, and light exposure assessment in night workers with and without shift work disorder. Chronobiol Int (2012) 0.96
A randomized, double-blind, placebo-controlled, crossover study of XP13512/GSK1838262 in the treatment of patients with primary restless legs syndrome. Sleep (2009) 0.96
Vulnerability to insomnia: the role of familial aggregation. Sleep Med (2007) 0.96
Insomnia, comorbidity, and risk of injury among insured Americans: results from the America Insomnia Survey. Sleep (2012) 0.95